Muscarinic M3 receptor antagonists with (2R)-2-[(1R)-3,3-Difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 13, 2003, Pages 2167-2172

  Ogino, Yoshio ^a   Ohtake, Norikazu ^a   Kobayashi, Kensuke ^a   Kimura, Toshifumi ^a   Fujikawa, Toru ^a   Hasegawa, Takuro ^a   Noguchi, Kazuhito ^a   Mase, Toshiaki ^a  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETANILIDE DERIVATIVE; AMINE; DIAMINE; FUNCTIONAL GROUP; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR ANTAGONIST; NITROGEN;

ARTICLE; DERIVATIZATION; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG SELECTIVITY; DRUG STRUCTURE; RECEPTOR AFFINITY; STRUCTURE ANALYSIS;

EID: 0037871784     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00350-0     Document Type: Article

References (9)

1. Doods H.N. Drug News Perspect. 1992;345.
2. Wang P., Luthin G.R., Ruggieri M.R. J. Pharmacol. Exp. Ther. 273:1995;959.
3. Alabaster V.A. Life Sci. 60:1997;1053.
4. Takeuchi, M.; Naito, M.; Morihira, K.; Ikeda, M.; Isomura, Y. Jpn. Kokai Tokkyo Koho 1995, JP 07258250; Chem. Abstr. 175858.
5. Miyachi H., Kiyota H., Segawa M. Bioorg. Med. Chem. Lett. 8:1998;2163.
6. Mitsuya M., Kobayashi K., Kawakami K., Satoh A., Ogino Y., Kakikawa T., Ohtake N., Kimura T., Hirose H., Sato N., Numazawa T., Hasegawa T., Noguchi K., Mase T. J. Med. Chem. 43:2000;5017.
7. Disse B., Speck G.A., Rominger K.L., Witek T.J. Jr., Hammer R. Life Sci. 64:1999;457.
8. Mitsuya M., Mase T., Tsuchiya Y., Kawakami K., Hattori H., Kobayashi K., Ogino Y., Fujikawa T., Satoh A., Kimura T., Noguchi K., Ohtake N., Tomimoto K. Bioorg. Med. Chem. 7:1999;2555.
9. Cheng Y.C., Prusoff W.H. Biochem. Pharmacol. 22:1973;3099.